ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕

News from the ECOG-ACRIN Cancer Research Group
June 29, 2026
June 29, 2026
Categories
  • From the Co-Chairs

From the Co-Chairs, June 2026

An update on federal funding and policy developments shaping the future of cancer research
Do you like it?
0 Read more
June 29, 2026
June 29, 2026
Categories
  • Active Clinical Trials

Coming Soon: EAA242 for Patients With Early Relapse of Multiple Myeloma

This trial is testing an immune-based treatment combination (teclistamab and pomalidomide) for patients with multiple myeloma that has come back early
Do you like it?
0 Read more
June 29, 2026
Patient on PET-CT scan table
June 29, 2026
Categories
  • Active Clinical Trials

Trial Spotlight: Neha Vapiwala Provides an Update on the EA8191/INDICATE Study for Patients With Prostate Cancer Showing Signs of Recurrence After Surgery

This study is using PET imaging to guide treatment for prostate cancer recurrence
Do you like it?
0 Read more
June 29, 2026
Research definition
June 29, 2026
Categories
  • Trial Results

Trial Results: ECOG-ACRIN Research at ASCO and SNMMI 2026

The latest findings in brain tumors, breast cancer, kidney cancer, lung cancer, Merkel cell carcinoma, and precision oncology
Do you like it?
0 Read more
June 29, 2026
News in Brief image
June 29, 2026
Categories
  • News in Brief

News in Brief, June 2026

Timely information about research presented at medical meetings, recognition of research leaders, and more
Do you like it?
0 Read more

A blog to share information with our members, staff, and the cancer research community

✕

Categories

  • From the Co-Chairs
  • Active Clinical Trials
  • Institution Spotlights
  • Special Topics
  • People
  • News in Brief
  • Trial Results
  • Active ECOG-ACRIN Trials
  • ECOG-ACRIN.org
STAY UP TO DATE

Opt in to ensure we deliver this monthly blog directly to your inbox. We will never share your email.

Select list(s) to subscribe to


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}